BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12371956)

  • 1. Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease.
    Gattone VH; Ricker JL; Trambaugh CM; Klein RM
    Kidney Int; 2002 Nov; 62(5):1560-9. PubMed ID: 12371956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice.
    Ricker JL; Gattone VH; Calvet JP; Rankin CA
    J Am Soc Nephrol; 2000 Oct; 11(10):1837-1847. PubMed ID: 11004214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
    Gattone VH; MacNaughton KA; Kraybill AL
    Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF-related growth factors in the pathogenesis of murine ARPKD.
    MacRae Dell K; Nemo R; Sweeney WE; Avner ED
    Kidney Int; 2004 Jun; 65(6):2018-29. PubMed ID: 15149315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.
    Gattone VH; Maser RL; Tian C; Rosenberg JM; Branden MG
    Dev Genet; 1999; 24(3-4):309-18. PubMed ID: 10322639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-myc antisense oligonucleotide treatment ameliorates murine ARPKD.
    Ricker JL; Mata JE; Iversen PL; Gattone VH
    Kidney Int; 2002 Jan; 61(1 Suppl):S125-31. PubMed ID: 11841626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk mice.
    Nakanishi K; Gattone VH; Sweeney WE; Avner ED
    Pediatr Nephrol; 2001 Jan; 16(1):45-50. PubMed ID: 11198603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
    Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of autosomal recessive polycystic kidney disease (ARPKD).
    Al-Bhalal L; Akhtar M
    Adv Anat Pathol; 2008 Jan; 15(1):54-8. PubMed ID: 18156813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
    Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
    J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.
    Ostrom L; Tang MJ; Gruss P; Dressler GR
    Dev Biol; 2000 Mar; 219(2):250-8. PubMed ID: 10694420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic kidney disease--the ciliary connection.
    Ong AC; Wheatley DN
    Lancet; 2003 Mar; 361(9359):774-6. PubMed ID: 12620752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.
    Cowley BD; Smardo FL; Grantham JJ; Calvet JP
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8394-8. PubMed ID: 3479800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
    Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
    Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Cux-1 and p21 in polycystic kidneys from Pkd1 null and cpk mice.
    Sharma M; Brantley JG; Alcalay NI; Zhou J; Heystek E; Maser RL; Vanden Heuvel GB
    Kidney Int; 2005 Feb; 67(2):432-42. PubMed ID: 15673290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).
    Sweeney WE; Avner ED
    Cell Tissue Res; 2006 Dec; 326(3):671-85. PubMed ID: 16767405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation.
    Woollard JR; Punyashtiti R; Richardson S; Masyuk TV; Whelan S; Huang BQ; Lager DJ; vanDeursen J; Torres VE; Gattone VH; LaRusso NF; Harris PC; Ward CJ
    Kidney Int; 2007 Aug; 72(3):328-36. PubMed ID: 17519956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells.
    Veizis IE; Cotton CU
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F474-82. PubMed ID: 15522985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.